XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Deficit) (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

The following weighted-average assumptions were used to estimate the fair value of options granted during the year ended December 31, 2022 and 2021 for the Monte-Carlo simulation:

 

   Year Ended
December 31,		 
   2022   2021 
Vesting Hurdle Price  $19.39    - 
Term (years)   5.00    - 
Expected stock price volatility   103.7%   - 
Risk-free rate of interest   1.32%   - 
Summary of Option Activity

A summary of options activity under the Company’s stock option plan for the year ended December 31, 2022 is presented below:

 

   Number of Shares   Weighted Average Exercise Price   Total Intrinsic Value   Weighted Average Remaining Contractual Life (in years) 
Outstanding as of December 31, 2021   1,235,000   $2.14   $1,488,000    4.0 
Employee options granted   50,000    1.51    -    1.4 
Employee options expired   (100,000)   1.90    -    - 
Employee options forfeited   (35,000)   1.50    -    - 
Outstanding as of December 31, 2022   1,150,000   $2.15   $-    3.3 
Options vested and exercisable as of December 31, 2022   1,135,000   $2.16   $-    3.3 
Schedule of Restricted Stock Units

The RSUs granted to each executive employee are as follows:

 

         Total RSUs   Market Cap Vesting Thresholds 
Officer Name  Title  Grant Date  Granted   $ 50 million   $ 100 million   $ 150 million   $ 300 million 
Charles Allen  Chief Executive Officer  1/2/2022   694,444    173,611    173,611    173,611    173,611 
Michal Handerhan  Chief Operations Officer  1/2/2022   444,444    111,111    111,111    111,111    111,111 
Michael Prevoznik  Chief Financial Officer  1/2/2022   222,224    55,556    55,556    55,556    55,556 
Manish Paranjape  Chief Technology Officer  2/22/2022   160,184    40,046    40,046    40,046    40,046 
          1,521,296    380,324    380,324    380,324    380,324 
Summary of Restricted Stock

A summary of the Company’s restricted stock units granted under the 2021 Plan during the year ended December 31, 2022 are as follows:

 

   Number of
Restricted
Stock Units		   Weighted
Average Grant
Day Fair Value		 
Nonvested at December 31, 2021   29,363   $5.96 
Granted   1,670,569    3.28 
Vested   (109,379)   2.29 
Forfeited   -    - 
Nonvested at December 31, 2022   1,590,553   $3.39 
Schedule of Stock-based Compensation Expense

Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the years ended December 31, 2022 and 2021 was as follows:

 

   2022   2021 
   For the Year Ended December 31, 
   2022   2021 
Employee bonus stock awards  $894,027   $- 
Employee stock option awards   97,142    11,932,409 
Employee restricted stock unit awards   1,575,475    2,993,146 
Non-employee restricted stock awards   225,207    352,640 
Series C-2 Allocation   -    179,277 
Stock-based compensation  $2,791,851   $15,457,472 
Summary of Warrant Activity

The following is a summary of warrant activity for the years ended December 31, 2022 and 2021:

 

   Number of Warrants 
Outstanding as of December 31, 2020   250,323 
Issuance of Series C Warrants   200,000 
Warrants exercise for cash   (200,000)
Issuance of Warrants pursuant to Registered Direct Offering   712,500 
Fractional shares adjusted for reverse split   (29)
Outstanding as of December 31, 2021   962,794 
Expiration of warrants   (50,294)
Outstanding as of December 31, 2022   912,500 
2021 Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

   Year Ended
December 31,		 
   2022   2021 
Exercise price  $1.51   $2.14 
Term (years)   5.00     2.50-3.30  
Expected stock price volatility   165.8%   185.9%
Risk-free rate of interest   2.77%   0.34%